Neovasc (Richmond, British Columbia) has announced that its still investigational Tiara transcatheter mitral valve prosthesis has been implanted in a human patient for the first time. The device was designed specifically to treat mitral regurgitation. Once implanted, it’s made to conform to the heart’s continuous motion while preserving the natural shape of the mitral valve.
More about the case, as reported by the company in the announcement:
Commenting on the procedure, [Dr. Anson Cheung, Professor of Surgery and Director of Cardiac Transplant, St. Paul’s Hospital, Vancouver, BC] stated, “This 73 year-old male patient had severe functional mitral regurgitation and was considered an extremely high risk candidate for conventional valve repair or replacement surgery. The transapical implantation of the Tiara valve was completed quickly and without complications. It resulted in a well-functioning bioprosthetic valve with no significant paravalvular leak or residual MR.”
Dr. Cheung added, “We are very pleased that this first implantation went so smoothly and that the patient’s outcome to date is so positive. His recovery has been uneventful and we will continue to follow him closely over the coming months. The ability to implant a prosthetic mitral heart valve using a transcatheter, minimally-invasive approach instead of conventional open chest, open heart surgery would prov
Flashback: Neovasc Tiara Transcatheter Mitral Valve in Pre-Clinical Trials…
Product page: Neovasc Tiara…
Press release: Neovasc Inc. Announces Successful First Human Implant of Tiara™ Transcatheter Mitral Valve…
